Follow-The-Filings

ANVS Annovis Bio

Annovis Bio earnings company data as of 4:48 AM ET 10/4

  • 1 of 1 EPS beats

History

2 periods · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -0.46 -0.40 Beat
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
8-K 5.07,9.01
424B5
8-K 1.01,7.01,9.01
424B5
8-K 2.02,9.01
10-Q
DEFA14A
8-K 1.01,7.01,9.01
424B5
8-K 5.02,9.01
8-K 2.02,9.01
10-K
8-K 7.01,9.01
8-K 7.01,9.01
8-K 2.02,9.01
10-Q
424B5
8-K 1.01,8.01,9.01
424B5
8-K 1.01,7.01,8.01,9.01
8-K 5.02,9.01
8-K 5.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period May 20, 2026
4 Period Apr 2, 2026
4 Period Dec 8, 2025
4 Period Nov 24, 2025
4/A Period Nov 24, 2025

7 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice